期刊文献+

琥珀酸索利那新、盐酸坦索罗辛单用或联用治疗经尿道离子束刀前列腺切除术后膀胱过度活动症效果对比 被引量:9

Effect of solifenacin and tamsulosin used alone or combined treatment for overactive bladder after transurethral prostate resection by ion beam knife
在线阅读 下载PDF
导出
摘要 目的探讨琥珀酸索利那新、盐酸坦索罗辛单用或联用治疗经尿道离子束刀前列腺切除术后膀胱过度活动症的临床效果。方法选取我院近年来收治的经尿道离子束刀前列腺切除术后膀胱过度活动症患者84例,采用随机数字表法分为A组、B组和C组,每组各28例,分别给予琥珀酸索利那新单用、盐酸坦索罗辛单用和两种药物联用,比较三组患者术后膀胱阵发性痉挛疼痛次数,膀胱痉挛持续时间,拔管后尿频、尿急改善情况,手术前后OABSS评分、IPSS评分及QOL评分等。结果术后第3天,A组、B组和C组膀胱阵发性痉挛疼痛次数分别为(1.20±0.23)次、(2.04±0.31)次、(0.85±0.19)次;膀胱痉挛持续时间分别为(0.19±0.05)h、(0.25±0.07)h、(0.14±0.04)h。C组术后第3天膀胱阵发性痉挛疼痛次数和膀胱痉挛持续时间显著优于A、B组,且A组患者各项指标优于B组,差异有统计学意义(P<0.05);A组、B组和C组拔管后第3天尿频频率分别为(6.43±2.02)次/24 h、(9.27±3.18)次/24 h、(4.15±1.56)次/24 h;A组、B组和C组拔管后尿急频率分别为(5.60±1.42)次/24 h、(8.15±1.68)次/24 h、(4.19±1.30)次/24 h;C组患者拔管后第1、3天尿频和尿急频率均显著优于A、B组,且A组患者各项指标优于B组,差异有统计学意义(P<0.05);C组患者术后OABSS评分、IPSS评分及QOL评分均显著优于A、B组,且A组患者各项指标优于B组,差异有统计学意义(P<0.05)。结论琥珀酸索利那新与盐酸坦索罗辛联用治疗可有效缓解行尿道离子束刀前列腺切除患者术后膀胱过度活动,提高生活质量,效果优于琥珀酸索利那新、盐酸坦索罗辛单用。 Objective To investigate the clinical efficacy of solifenacin and tamsulosin used alone or combined treatment for overactive bladder after transurethral prostate resection by ion beam knife. Methods 84 patients were randomly divided into 3 groups,group A( 28 patients) with solifenacin used alone treatment,group B( 28 patients) with tamsulosin used alone treatment and group C( 28 patients) with solifenacin combined with tamsulosin treatment; and the postoperative bladder paroxysmal spasm pain frequency,duration of bladder spasm,situation improvment of frequency and urgency of urination after extubation,before and after operation OABSS score,IPSS score and QOL score of 3 groups were compared. Results On 3rd day after operation,the bladder paroxysmal spasm pain frequency of group A,group B and group C were separately( 1. 20 ± 0. 23) times,( 2. 04 ± 0. 31) times,( 0. 85 ± 0. 19) times; The duration of bladder spasm were( 0. 19 ± 0. 05) h,( 0. 25 ± 0. 07) h,( 0. 14 ± 0. 04) h respectively. The bladder paroxysmal spasm pain frequency and duration of bladder spasm on 3rd after operation of group C was significantly better than that of group A and group B,and the same index of group A was significantly better than that of group B( P〈0. 05). The urination frequency after extubation in 3 days of group A,group B and group C were( 6. 43 ± 2. 02) times /24 h,( 9. 27 ± 3. 18) times /24 h,( 4. 15 ±1. 56) times /24 h; The urination urgency after extubation on 3rd of group A,group B and group C were( 5. 60 ± 1. 42)times /24 h,( 8. 15 ± 1. 68) times /24 h,( 4. 19 ± 1. 30) times /24 h; The frequency and urgency of urination after extubation on 3rd of groups C was significantly better than that of group A and group B,and the same index of group A was significantly better than that of group B( P〈0. 05). The OABSS score,IPSS score and QOL score after operation of group C was significantly better than that of group A and group B,and the same index of group A was significantly better than that of group B( P〈0. 05). Conclusion Compared with solifenacin and tamsulosin used alone,solifenacin combined with tamsulosin in patients with transurethral prostate resection by ion beam knife can relieve overactive bladder and improve life quality.
出处 《实用药物与临床》 CAS 2014年第6期774-777,共4页 Practical Pharmacy and Clinical Remedies
关键词 琥珀酸索利那新 盐酸坦索罗辛 尿道离子束刀前列腺切除术 膀胱过度活动症 Solifenacin Tamsulosin Transurethral prostate resection by ion beam knife Overactive bladder
  • 相关文献

参考文献15

二级参考文献104

共引文献238

同被引文献74

  • 1郑霁,沈文浩,鄢俊安,张恒,李为兵,宋波,周占松.尿动力学检查在指导防治TURP术后膀胱颈挛缩致上尿路功能损害中的作用[J].微创泌尿外科杂志,2014,3(3):186-189. 被引量:2
  • 2吴荃,肖向茜,刘树业,刘宇,石建党,王克明,张琚.雌二醇通过调节上皮细胞系的旁分泌促进前列腺间质细胞增殖和分化[J].中国病理生理杂志,2007,23(7):1382-1387. 被引量:4
  • 3KNUTSON T, EDLUND C, FALL M, et al. BPH with coexisting overative bladder dysfunction-an everyday urological dilemma[J]. Neurourol Urodyn, 2001, 20(3): 237-247.
  • 4HOMMA Y, KAKIZAKI H, YAMAQUCHI O, et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder di- ary and the overactive bladder symptoms score[J]. Urology, 2011, 77(1): 60-64.
  • 5PATRA P B, PATRA S. Research findings on overactive bladder[J]. Curr Urol, 2015, 8(1): 1-21.
  • 6EGLEN R M. Overview of muscarinic receptor subtypes[J]. Handb Exp Pharmaeol, 2012, 1(208): 3-28.
  • 7SIGALA S, MIRABELLA G, PERONI A, et al. Differential gene of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder[J]. Urology, 2002, 60(4): 719-725.
  • 8YAMADA S, KURAOKA S, OSANO A, et ah Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor blinding[J]. Int Neurourol J, 2012, 16(3): 107-115.
  • 9YOSHIDA A, SEKI M, NASRIN S, et al. Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard[J]. Urology, 2011, 78(3): 1357-1366.
  • 10CHAIYAPRASITHI B, MANG C F, KILBINGER H, et al. Inhi- bition of human detrusor contraction by a urothelium derived factor[J]. J Urol, 2003, 170(5): 1897-1900.

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部